Sartorius Stedim Biotech S.A.
SRTOY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18,364,465 | $22,870,508 | $26,682,047 | $35,269,338 |
| - Cash | $678,900 | $116,600 | $107,100 | $223,626 |
| + Debt | $2,869,600 | $3,682,000 | $1,135,600 | $625,516 |
| Enterprise Value | $20,555,165 | $26,435,908 | $27,710,547 | $35,671,228 |
| Revenue | $2,780,000 | $2,775,500 | $3,492,700 | $2,886,977 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Gross Profit | $1,206,700 | $1,233,500 | $1,834,500 | $1,553,003 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| EBITDA | $670,500 | $755,700 | $1,330,700 | $811,959 |
| % Margin | 24.1% | 27.2% | 38.1% | 28.1% |
| Net Income | $175,100 | $309,700 | $876,100 | $414,400 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS Diluted | 0.18 | 0.34 | 0.95 | 0.45 |
| % Growth | -47.1% | -64.2% | 111.1% | – |
| Operating Cash Flow | $815,100 | $629,700 | $612,300 | $695,971 |
| Capital Expenditures | -$339,800 | -$473,600 | -$430,600 | -$323,987 |
| Free Cash Flow | $475,300 | $156,100 | $181,700 | $371,984 |